Market research
COG.LSE Cambridge Cognition Holdings Plc
LSE GBP Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 17M
- P/E ratio
- Not available
- Analyst target
- 61.667
- Dividend yield
- Not available
- Beta
- 0.81
Profile
Company facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- GB00B8DV9647
- Market cap
- 17M
- P/E ratio
- Not available
- Analyst target
- 61.667
- Dividend yield
- Not available
- Beta
- 0.81
About
About Cambridge Cognition Holdings Plc
Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers sensitive, precise and objective measures of cognitive function, correlated to neural networks; voice analysis, an automated speech recognition tool for monitoring neurological and psychiatric disorders; and high frequency testing that detects fluctuations in brain health with short tasks over regular timepoints. It also provides electronic questionnaires and scales (eCOA), a digital bespoke questionnaires that collects data within tight deadlines; and data quality management. Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the COG.LSE discussion.
5 years, 5 months ago
Cambridge Cognition Holdings Plc is currently in a long term uptrend where the price is trading 84.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.0.
Finally, its free cash flow grew by 213.3% to $586K since the same quarter in the previous year.
Based on the above factors, Cambridge Cognition Holdings Plc gets an overall score of 3/5.